跳至主要内容

Fischer Indole Synthesis Reaction

 

In 1883, E. Fischer and F. Jourdan treated pyruvate with 1-methylphenylhydrazone with HCl alcohol solution to obtain 1-methylindole-2-carboxylic acid. After this discovery, the Fischer indole synthesis reaction became a very significant method for the synthesis of substituted indoles. The Fischer indole synthesis reaction is a simple and rapid synthesis method for arylhydrazones obtained from the reaction of aldehydes or ketones with arylhydrazones. 

The drug discovery of Medicilon mainly include chemistry (synthetic chemistry, medicinal chemistry) and biology. Among them, our chemistry team can undertake multi-dimensional business cooperation such as custom synthesis of compunds, compound library construction, SAR compound synthesis and screening, compound structure and biological activity optimization.

This reaction is followed by cyclization to generate polysubstituted indoles. The phenylhydrazone generated in the reaction is heated and rearranged under acid catalysis to eliminate a molecule of ammonia to obtain 2-substituted or 3-substituted indole derivatives. In practical operation, aldehyde or ketone and equivalent phenylhydrazine can be heated to reflux in acid to obtain phenylhydrazone, which can be rearranged immediately under acid catalysis to eliminate ammonia to obtain indole compounds. The commonly used catalysts are zinc chloride, boron trifluoride, polyphosphoric acid, AcOH, HCl, trifluoroacetic acid, etc. Under the catalysis of Lewis acid, this reaction can usually be carried out under mild conditions, while protic acid usually needs to be heated to higher temperature.

In recent years, with the development of coupling reactions, people have developed a more convenient coupling reaction method. Fisher's indole synthesis method has been widely used in the field of alkaloid and pharmaceutical synthesis, even an indispensable method. A synthetic method for aryl hydrazones via the Buchwald-Hartwig coupling of aryl halides and hydrazones was also developed (modified by Buchwald).



Reaction mechanism

Aldehydes, ketones and aryl hydrazones react, and the generated aryl hydrazones are heated under an acidic catalyst, and undergo a single-electron transfer cyclization to generate substituent indoles.



Response instance

 



Synthesis of Peduncularine. Roberson, C. W.; Woerpel, K. A, J. Am. Chem. Soc. 2002, 124, 11342.


References

1. Name Reactions (A Collection of Detailed Reaction Mechanisms), Jie Jack Li, Fischer indole synthesis, pages 253-254.

2. Organic Chemistry Portal: http://www.organic-chemistry.org/namedreactions/fischer-indole-synthesis.shtm

3. Chemical station: http://www.chem-station.com/cn/reactions/2014/05/%E8%B4%B9%E8%88%8D%E5%B0%94%E5%90%B2% E5%93%9A%E5%90%88%E6%88%90-fischer-indole-synthesis.html

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati